Baxter reports Q2 growth; Will the device ID program work?;

@FierceMedDev: Medtronic appears to be negotiating with Indian device giant Trivitron Healthcare for a "strategic investment." More | Follow @FierceMedDev

 @MarkHFierce: U.K. Sanofi site draws $7.8M investment for asthma inhaler production. Item | Follow @MarkHFierce

 @DamianFierce: Quest Dx and LabCorp are scaling back expectations after a tepid Q2. More | Follow @DamianFierce

> Should companies be legally allowed in the U.S. to obtain patents on genetic material, and on procedures that use that material for both medical diagnoses and treatments? A federal court will begin hearing arguments on the matter this week, Bloomberg reports. Story

> Baxter ($BAX) expects sales growth to reach 5-6% in its 2012 third quarter, excluding the impact of foreign currency, and earnings per diluted share of $1.12 to $1.14 before any special items. Release

> The FDA's new device ID plan is meant to keep patients safe, but will it work? Article

> The FDA has cleared pSivida's ($PSDV) investigational new drug application to treat posterior uveitis with its injectable sustained-release micro-insert, which means the company will advance to two Phase II trials to treat patients with posterior uveitis, enrolling 300 patients. Release

> Canada's Verisante Technology is gearing up for the commercial launch of new skin cancer diagnostic technology. Release

> Stanford's Henry Miller says the growing regulatory burden in the U.S. will force devicemakers to move their R&D and manufacturing operations overseas. Column

> AorTech, the company that manufactures polymer coatings for St. Jude Medical's ($STJ) Durata leads, is up for sale. Report

> Tornier in The Netherlands has appointed Shawn T. McCormick as its new chief financial officer as of Sept. 4, 2012. McCormick is a veteran medical device executive who previously served various leadership roles at Medtronic, ev3 and Lutonix. Release

Biotech News

 @FierceBiotech: Study: Low-income patients less likely to join cancer‬ trials. Report | Follow @FierceBiotech

 @JohnCFierce: Interesting approach--super high risk; EnVivo grabs ‪Alzheimer‬'s spotlight with promising PhIIb results. News | Follow @JohnCFierce

 @RyanMFierce: Innovation in ‪pharma‬ manufacturing is under-appreciated. Thinking about this as I cover Novartis' woes at Lincoln, NE plant. Hurt Q2 sales.  | Follow @RyanMFierce

> Faded star at Pfizer leads to discounted $68M IPO for Durata. Article

> Infinity restructures drug deal, raises $27.5M as it scrambles to refocus. News

> Multibillion-dollar R&D strategy is paying off for Novartis. More

Pharma News

 @FiercePharma: PDI expects $57M from deal to market 'newly FDA approved drug'. ‪Vivus‬ diet pill Qsymia, maybe? Release | Follow @FiercePharma

> New bill aims to mandate abuse-deterrent painkillers. Report

> Novartis leans on emerging markets, new meds to offset Diovan drop. News

> Plavix tops U.S. sales ranks, but not for long. More

CRO News

> Medpace adds clinical pharma unit for PhI trials. Story

> ScinoPharm will manufacture blockbuster hopeful Qsymia. Article

> Europe moves toward liberalizing clinical trial rules. More

> Study: Low-income patients less likely to join cancer trials. Report

> Indian regulators shutter 12 drug plants over enviro concerns. News

Vaccines News

> Galena stock jumps with NeuVax patent. Report

> Oral vax rides on advanced microparticles. News

> Silk could eliminate 'cold chain' need. Story

> MedImmune to cut 200 jobs, layoffs hit vax R&D. Article

> University of Birmingham explores attitudes toward polio vax in India. More

> HIV-positive patients approved for smallpox vax in an emergency. Item

Pharma Manufacturing News

> Novartis's Q2 sales hit after Excedrin production woes. News

> Sanofi plant adds 40 to produce SkyePharma product. More

> Docs reportedly get smuggled cancer drugs in Pakistan bazaar. Story

> J&J 'decree' upgrades cost 200 jobs in Puerto Rico. Article